» Authors » Bruno Michon

Bruno Michon

Explore the profile of Bruno Michon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 61
Citations 1337
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramjan S, Cole P, Blair-Thies M, Silverman L, Fredrickson A, Schembri A, et al.
Pediatr Blood Cancer . 2024 Dec; 72(3):e31469. PMID: 39654084
Treatment of acute lymphoblastic leukemia (ALL) is associated with neurocognitive deficits in young children. While computerized measures have been utilized in pediatric oncology research, they exclude patients below the age...
2.
Zhu Q, Nambiar R, Schultz E, Gao X, Liang S, Flamand Y, et al.
Br J Haematol . 2024 Aug; 205(5):1889-1898. PMID: 39143423
Bone toxicities are common among paediatric patients treated for acute lymphoblastic leukaemia (ALL) with potentially major negative impact on patients' quality of life. To identify the underlying genetic contributors, we...
3.
Aziz-Bose R, Cernik C, Umaretiya P, Ilcisin L, Kelly C, Valenzuela A, et al.
Pediatr Blood Cancer . 2024 Aug; 71(11):e31274. PMID: 39129149
Poverty-exposed children with cancer are more likely to experience adverse outcomes. Supplemental Nutrition Assistance Program (SNAP) benefits improve food insecurity and child health outcomes, and could be used to mitigate...
4.
Robichaud L, Felipe J, Duval M, Michon B, Olivier-dAvignon M, Perreault S, et al.
Curr Oncol . 2024 Apr; 31(4):2289-2304. PMID: 38668073
A recent measure was developed to assess the Quality of Life (QoL) of young people with advanced cancer and is available for parents and professionals (). The present study aimed...
5.
Brizini M, Michon B, Bedard M
J Pediatr Hematol Oncol . 2024 Apr; 46(5):e331-e333. PMID: 38652075
Multiple myeloma is a rare disease in pediatrics, where about 30 cases are described under 15 years old. It is even rarer when atypical multiple myeloma occurs in the context...
6.
Karvonen K, Umaretiya P, Koch V, Flamand Y, Aziz-Bose R, Ilcisin L, et al.
Hosp Pediatr . 2024 Jan; 14(2):e104-e106. PMID: 38239110
No abstract available.
7.
Mochon A, Lippe S, Krajinovic M, Laverdiere C, Marjerrison S, Michon B, et al.
Pediatr Hematol Oncol . 2023 Jul; 40(6):554-567. PMID: 37469296
Late effects such as neurocognitive issues and fatigue have been reported in childhood acute lymphoblastic leukemia (cALL) survivors. Yet, their association is often poorly understood. In this study, we wished...
8.
Welch J, Flamand Y, Stevenson K, Neuberg D, Athale U, Kelly K, et al.
Pediatr Blood Cancer . 2023 Jul; 70(11):e30560. PMID: 37461125
Background: Children treated for acute lymphoblastic leukemia (ALL) receive prolonged treatment, resulting in toxicities that affect health-related quality of life (HR-QoL). Longitudinal assessment of HR-QoL allows improved understanding of experiences...
9.
Umaretiya P, Koch V, Flamand Y, Aziz-Bose R, Ilcisin L, Valenzuela A, et al.
J Natl Cancer Inst . 2023 Jun; 115(10):1179-1187. PMID: 37261858
Background: Parent psychological distress during childhood cancer treatment has short- and long-term implications for parent, child, and family well-being. Identifying targetable predictors of parental distress is essential to inform interventions....
10.
Aziz-Bose R, Zheng D, Umaretiya P, Ilcisin L, Stevenson K, Koch V, et al.
Pediatr Blood Cancer . 2022 Sep; 69(11):e29933. PMID: 36069432
Social determinants of health (SDoH) are associated with stark disparities in cancer outcomes, but systematic SDoH data collection is virtually absent from oncology clinical trials. Trial-based SDoH data are essential...